These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25695617)

  • 1. Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload.
    Wu C; Dong S; Li Y
    Int J Mol Med; 2015 Apr; 35(4):893-900. PubMed ID: 25695617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
    Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
    J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
    Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
    FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
    Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
    Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
    Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-150 Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Liu W; Liu Y; Zhang Y; Zhu X; Zhang R; Guan L; Tang Q; Jiang H; Huang C; Huang H
    J Cell Biochem; 2015 Oct; 116(10):2166-76. PubMed ID: 25639779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.
    Ji Y; Qiu M; Shen Y; Gao L; Wang Y; Sun W; Li X; Lu Y; Kong X
    Int J Mol Med; 2018 Apr; 41(4):1909-1916. PubMed ID: 29393356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.
    Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ
    Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice.
    Chen C; Huo R; Tong Y; Sheng Y; Liu HB; Gao X; Nakajima O; Yang BF; Dong DL
    Cell Physiol Biochem; 2011; 28(1):25-32. PubMed ID: 21865845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
    Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
    Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy.
    Li X; Le HT; Sato F; Kang TH; Makishima M; Zhong L; Liu Y; Guo L; Bhawal UK
    Biochem Biophys Res Commun; 2020 Nov; 532(4):513-519. PubMed ID: 32896382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.
    Izumiya Y; Shiojima I; Sato K; Sawyer DB; Colucci WS; Walsh K
    Hypertension; 2006 May; 47(5):887-93. PubMed ID: 16567591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy.
    Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J
    Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress.
    Luo T; Chen B; Wang X
    Chem Biol Interact; 2015 Dec; 242():99-106. PubMed ID: 26428355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.